Satellos’ condensed consolidated interim financial statements for the three and nine months ended September 30, 2024, and the related management’s discussion and analysis (MD&A) will be available on ...
Creative Medical Technology (CELZ) announces the successful completion of an independent interim safety review by the Data Safety Monitoring ...
H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...
An estimated 23 percent of adults worldwide suffer from chronic low back pain, and as many as 84 percent of us will ...